Stay updated on Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page.

Latest updates to the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed in the Record History page. This updates the version history for the nct03150693 record.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved the general government funding/operating status notice from the page. Core trial record content and navigation remain unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedMultiple new versions of the record were posted, showing updated timestamps and occasional changes to fields such as Study Status and Contacts/Locations.SummaryDifference0.0%

- Check104 days agoChange Detected- Major update: introduces a government-operating-status notice and directs users to cc.nih.gov and opm.gov. - Version bumped from v3.1.0 to v3.2.0. If no deeper content changes are present, this indicates a maintenance/operational update rather than feature changes.SummaryDifference9%

Stay in the know with updates to Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page.